Wearable device uses direct olfaction neural stimulation to regulate emotions in real-time
AromaCue’s NeuroBridge™ septum device delivers targeted neural pulses to emotional processing centers for personalized wellness
AromaCue Technologies, a pioneer in neuroscience-based wellness solutions, today announced the launch of NeuroBridge™, the world’s first wearable septum device that delivers targeted neural stimulation to regulate emotional states in real-time. The revolutionary device leverages cutting-edge research in neurostimulation and integrates seamlessly with biometric monitoring to provide personalized emotional support through direct neural pathway activation.
Breakthrough technology meets precision neuroscience
The NeuroBridge™ device utilizes precisely calibrated electromagnetic pulses to stimulate the trigeminal nerve pathways that connect directly to the brain’s limbic system – the emotional processing center. By bypassing traditional pharmaceutical interventions, the device creates immediate and measurable changes in emotional states through targeted neural activation.
“We’ve developed a non-invasive method to directly influence the neural circuits responsible for emotional regulation,” said Dr. Sarah Chen, CEO and Co-Founder of AromaCue Technologies. “Our device provides the precision of neurostimulation with the convenience and discretion of a wearable accessory.”
Clinical foundation and research backing
The NeuroBridge™ system is built upon extensive research in transcranial and peripheral neurostimulation. Studies published in Nature Neuroscience have shown that targeted electromagnetic stimulation can modulate limbic system activity and reduce cortisol levels within minutes of application. Additional research from the Journal of Neural Engineering demonstrates that specific neural pulse patterns can improve cognitive performance and reduce anxiety by up to 60% in controlled settings.
The device’s neural stimulation methodology is supported by breakthrough research from institutions including MIT and Stanford, which have mapped the precise neural pathways that connect peripheral nerve stimulation points to emotional processing centers in the brain.
Intelligent integration with biometric data
NeuroBridge™ connects wirelessly to Apple Watch and other compatible devices to monitor key physiological markers including:
- Heart rate variability (HRV)
- Skin conductance
- Brainwave patterns (via EEG sensors)
- Sleep quality metrics
- Stress indicators
- Cortisol level estimation
The accompanying AromaCue app uses proprietary machine learning algorithms to detect emotional states and automatically trigger appropriate neural stimulation patterns. Users can also manually select from clinically-validated emotional regulation modes:
- Calm (parasympathetic activation sequences)
- Focus (prefrontal cortex enhancement patterns)
- Confidence (amygdala modulation protocols)
- Energy (noradrenergic pathway stimulation)
- Sleep (gamma-wave reduction sequences)
Real-world applications
Beta testing with over 500 participants showed remarkable results across various use cases:
- Public Speaking: 85% reduction in pre-presentation anxiety
- Flight Travel: 72% improvement in passenger comfort scores
- Workplace Stress: 68% decrease in afternoon cortisol levels
- Sleep Quality: 59% improvement in sleep onset time
- Focus Enhancement: 45% increase in sustained attention metrics
“I’ve struggled with presentation anxiety for years,” said beta tester Jennifer Martinez, a marketing executive from Austin. “The confidence stimulation protocol helped me achieve that calm, prepared mental state instantly. It’s like having a reset button for my emotional state.”
Safety and design excellence
The NeuroBridge™ device is constructed from medical-grade titanium and incorporates advanced biocompatible neural interface technology. The integrated neural stimulation unit delivers precisely controlled electromagnetic pulses at frequencies proven safe for daily use. The device features automatic safety shutoffs and adaptive power regulation based on individual neural response patterns.
The device has undergone extensive safety testing and received FDA clearance as a Class II medical device. Dr. Michael Torres, AromaCue’s Chief Medical Officer and former researcher at the National Institute of Mental Health, emphasized the rigorous safety protocols: “We’ve conducted comprehensive studies on stimulation parameters, frequency limits, and long-term neuroplasticity effects to ensure complete safety and optimal therapeutic outcomes.”
Advanced neural mapping technology
Each NeuroBridge™ device includes proprietary neural mapping capabilities that create a personalized stimulation profile for optimal effectiveness. The device learns individual neural response patterns over time, continuously refining stimulation parameters for maximum emotional regulation benefits.
“The beauty of direct neural stimulation is its precision,” explained Dr. Chen. “Unlike broad-spectrum interventions, we can target specific emotional circuits while leaving other neural functions completely unaffected.”
Availability and pricing
The NeuroBridge™ Neural Wellness System, including the device, comprehensive neural mapping session, and premium app access with AI-powered emotional coaching, will be available starting July 15, 2040, for $599. Monthly calibration and optimization services are available for $29.
Pre-orders begin today at aromacue.com, with early adopters receiving a 25% discount and exclusive access to beta features including custom neural protocol design and advanced biometric integration.
Our mission
“Think. Feel. Transform.“
AromaCue Technologies is committed to making emotional wellness as precise and accessible as modern neuroscience allows. By combining the latest neural stimulation research with intuitive technology, the company aims to democratize access to effective, non-pharmaceutical emotional regulation tools.
About aromaCue technologies
Founded in 2023 by neuroscientist Dr. Sarah Chen and former Tesla engineer David Kim, AromaCue Technologies develops evidence-based wellness solutions that leverage the power of targeted neural stimulation and biometric data. The company is based in San Francisco and backed by leading venture capital firms specializing in neurotechnology and health innovation.
DISCLAIMER: This is a speculative design exercise and fictional press release. The company and device do not actually exist. This content is created for conceptual and educational purposes only.
olfactronics 